Researchers at McMaster University have made a groundbreaking discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite ...
Tulane University biomedical engineers are testing a new device designed to rapidly detect life-threatening blood-clotting problems in trauma patients, potentially reducing diagnostic time from hours ...
A team of researchers have made a new discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite treatment with full-dose ...
(Reuters) -The U.S. Food and Drug Administration approved French drugmaker Sanofi's hemophilia therapy, introducing a new type of treatment administered every two months for patients with the rare ...
What Is Cablivi, and Why Does It Matter? Cablivi (caplacizumab) is an injectable medicine used to treat a rare and serious blood condition called acquired thrombotic thrombocytopenic purpura (aTTP).
A European medical regulator says it has found a possible link to the cause of the extremely rare blood clot disorder, tied to the Johnson and Johnson vaccine. It's the potential finding that medical ...
Blood disorders affect millions of Americans, yet many don’t realize these conditions can sometimes transform into something far more serious. With approximately 1.3 million people currently living ...
Researchers at McMaster University have made a groundbreaking discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results